Max Robotics — Global Service Robot Directory + US Certification

About

Mitsuru Tomizawa is a urologic surgeon and researcher whose work focuses on advancing surgical outcomes in kidney and prostate cancers through the adoption and refinement of robotic-assisted techniques. His key research areas include partial nephrectomy for complex renal tumors, radical prostatectomy for localized prostate cancer, and the comparative effectiveness of open versus minimally invasive approaches. In a landmark 2022 study on perioperative outcomes of open and robot-assisted partial nephrectomy in patients with moderate to high-complexity renal tumors, Tomizawa demonstrated the safety and efficacy of robotic surgery in challenging cases, contributing to the growing evidence base for minimally invasive nephron-sparing surgery. His work on trends in primary treatment for localized prostate cancer, with over 12,000 patients, highlighted how the introduction of robotic surgery shifted treatment patterns. Tomizawa has also investigated the clinical significance of pelvic lymph node dissection during robot-assisted radical prostatectomy, using propensity score matching to assess diagnostic and therapeutic benefits. His more recent studies examine intraoperative tumor capsule injury during partial nephrectomy and compare renal function outcomes after radical cystectomy with different urinary diversion techniques. With over 25 citations across his most-cited papers, Tomizawa’s research is shaping best practices in urologic oncology, particularly in optimizing surgical precision and patient outcomes.